Oklo's Q4 2025 print, contained in the 10-K filed with the SEC on March 17, 2026, for the period ending December 31, 2025, delivered a straightforward finding: the company recorded no revenue, reported an EPS of -$0.72 on an SEC basis against a Benzinga consensus estimate of -$0.17, and provided no margin metrics because there is no operating business to measure. The miss is not a rounding error or a one-quarter anomaly — it is a structural confirmation that Oklo remains a pre-revenue development-stage entity trading at a $12.8 billion market capitalization.
The Result
The Benzinga consensus estimate for Q4 2025 EPS stood at -$0.17. The reported figure used for surprise calculation came in at -$0.27, producing a miss of approximately -59%. The SEC-filed EPS of -$0.72 — the figure drawn directly from the 10-K — represents a substantially deeper loss than even the already-negative consensus anticipated. Revenue was zero, as it has been, rendering a revenue surprise percentage not applicable. There is no gross margin, operating margin, or net margin to report because the numerator in each calculation — revenue — does not exist.
Print Scorecard
| Metric | Actual | Estimate | Surprise |
| EPS (consensus basis) | -$0.27 | -$0.17 | -58.8% |
|---|---|---|---|
| EPS (SEC 10-K filing) | -$0.72 | -$0.17 | N/M |
| Revenue | $0 | N/A | N/A |
| Gross Margin | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A |
Sources: SEC 10-K filed 2026-03-17 (period ending 2025-12-31); Benzinga consensus estimates as provided. N/M denotes not meaningful given the magnitude of divergence between the SEC-filed figure and the consensus.
Narrative Test
The prevailing narrative entering this print framed Oklo as a transformative nuclear investment — a small modular reactor company with a current price of $30 carrying the potential to generate significant generational wealth for investors. That framing is now being stress-tested against a stock trading at $73.63, up roughly 99% over the trailing 52 weeks, which means the millionaire-potential narrative has partially self-fulfilled in price terms even as the underlying business has made no transition from development to operation.
The print does not confirm the narrative. It complicates it in a specific and measurable way: the gap between what media coverage and promotional framing describe — a company on the verge of commercializing compact nuclear reactors — and what the 10-K documents is not narrow. The 10-K documents a company with zero revenue, losses that exceeded analyst estimates by a substantial margin, and no margin structure. The short float at 18.84% suggests a meaningful cohort of market participants has already registered this divergence. The day-after price reaction of -5.76% is modest relative to the scale of the fundamental miss, which itself indicates how much of the stock's value resides in optionality and regulatory progress rather than current financial performance.
The narrative state arriving at this print was essentially a speculative thesis about future technology adoption. The print neither destroys that thesis nor validates it — it simply confirms that the thesis remains entirely forward-looking, with the financial record providing no current support.
Forensic Dissection
The single most important data point in this filing is the divergence between the consensus EPS of -$0.17 and the SEC-filed EPS of -$0.72. That gap — $0.55 per share — requires explanation that the provided data does not fully supply, but the structure of the divergence suggests either one-time charges, non-cash stock-based compensation, or development costs that were not fully captured in the sell-side model. For a pre-revenue company, operating expense control is the only financial lever available, and the filing indicates that lever is moving in the wrong direction relative to expectations.
With no revenue, every dollar of expense flows directly to the loss line. The absence of gross margin data is itself a data point: Oklo has not yet crossed the threshold where it can demonstrate the unit economics of its reactor technology at any commercial scale. The 10-K, covering fiscal year 2025, closes the year with the company still entirely dependent on capital markets for survival rather than customer contracts for revenue.
The headline from Barron's referencing a "big hurdle" cleared — most likely related to licensing or regulatory progress with the Nuclear Regulatory Commission — is the type of milestone that sustains the speculative premium embedded in the stock. Regulatory clearance is a legitimate value-creating event for a development-stage nuclear company. However, it does not appear on the income statement, and the forensic record as of the 10-K filing date shows no translation of that regulatory progress into any financial output.
The Q1 2026 earnings call highlights referenced in recent GuruFocus coverage describe "strategic advances amid financial challenges" — a formulation that precisely captures the tension between the narrative and the filing: strategic progress is real, financial challenges are structural.
Four-Bullet Watchlist
- NRC licensing milestones: Any formal action on Oklo's combined license application represents the single most material near-term catalyst; monitor for NRC docket updates and any slippage in the agency's review timeline over the next 30 to 60 days.
- Cash burn trajectory: With no revenue and losses running significantly above consensus estimates, the rate of cash consumption disclosed in Q1 2026 filings will determine whether and when Oklo returns to capital markets; watch the balance sheet line items in the next 10-Q.
- Power purchase agreement disclosures: Management has referenced potential offtake agreements as a forward indicator of commercialization; any signed or announced PPA would represent the first tangible bridge between the speculative narrative and the financial record.
- Short interest dynamics: At 18.84% of float short, any regulatory or contractual announcement could compress that position rapidly; conversely, continued delays without revenue signals could attract additional short positioning — monitor weekly FINRA short interest data through Q2.
The structural reality of Oklo's financial record is that a $12.8 billion market capitalization resting entirely on a development-stage entity with zero revenue and widening losses is not a valuation supported by current fundamentals — it is a bet on a regulatory and technological timeline that the 10-K does not yet have the capacity to confirm or deny.